Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : $109.0 million
Deal Type : Series B Financing
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Details : The financing will be used to advance the company's platform and first drug candidates towards the clinic for a first indication in Stop Codon Disease.
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
September 08, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : $109.0 million
Deal Type : Series B Financing